403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Avant Technologies Inc
(MENAFN- Baystreet) 10:40 AM EST - Avant Technologies Inc: Announced a newly published study from the Mayo Clinic reinforces the critical role of the“longevity protein” a-Klotho in vascular health and aging. The research, appearing in the Journal of the American Heart Association, demonstrates a strong association between declining a-Klotho levels and arterial stiffness, endothelial dysfunction, vascular calcification, and significantly reduced patient survival. Avant Technologies Inc
shares O are trading unchanged at $0.29.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment